S&P 500 Futures
(0.11%) 5 333.00 points

Dow Jones Futures
(0.03%) 40 150 points

Nasdaq Futures
(0.17%) 18 667 points

Oil
(-0.05%) $80.02

Gas
(0.88%) $2.65

Gold
(1.10%) $2 444.10

Silver
(2.93%) $32.18

Platinum
(0.29%) $1 093.20

USD/EUR
(0.00%) $0.920

USD/NOK
(-0.02%) $10.67

USD/GBP
(0.07%) $0.788

USD/RUB
(-0.25%) $90.75

Realtime updates for Milestone Pharmaceuticals [MIST]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Last Updated17 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

-0.57% $ 1.740

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate...

Stats
Today's Volume	251 931
Average Volume	329 180
Market Cap	92.67M
EPS	$0 ( 2024-05-09 )
Next earnings date	( $-0.260 ) 2024-06-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.250
ATR14	$0.00400 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-07	Wills Robert James	Buy	30 000	Stock Option (right to buy)
2023-06-07	Tomsicek Michael John	Buy	30 000	Stock Option (right to buy)
2023-06-07	Pasternak Richard C	Buy	30 000	Stock Option (right to buy)
2023-06-07	Liebert Debra K.	Buy	30 000	Stock Option (right to buy)
2023-06-07	Giles Lisa M.	Buy	30 000	Stock Option (right to buy)

INSIDER POWER
1.90
Last 95 transactions
Buy: 18 033 611 \| Sell: 4 881 578

Volume Correlation

Long: -0.21 (neutral)

Short: -0.95 (very strong negative)

Signal:(35.499) Neutral

Milestone Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Milestone Pharmaceuticals Correlation - Currency/Commodity

0.12
( neutral )

0.36
( neutral )

0.00
( neutral )

0.00
( neutral )

0.00
( neutral )

0.18
( neutral )

Milestone Pharmaceuticals Financials

Annual	2023
Revenue:	$1.00M
Gross Profit:	$402 000 (40.20 %)
EPS:	$-1.390

FY	2023
Revenue:	$1.00M
Gross Profit:	$402 000 (40.20 %)
EPS:	$-1.390

FY	2022
Revenue:	$5.00M
Gross Profit:	$4.52M (90.40 %)
EPS:	$-1.350

FY	2021
Revenue:	$15.00M
Gross Profit:	$15.00M (100.00 %)
EPS:	$-1.460

Financial Reports:

No articles found.

Milestone Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.